Does Surgical Prophylaxis with Teicoplanin Constitute a Therapeutic Advance?

References

• National Academy of Sciences, National Research Council, Division of Medical Sciences, Ad Hoc Committee on Trauma. Postoperative wound infections: the influence of ultraviolet irradiation on the operating room and of various other factors. Ann Surg 1964; 160: Suppl. 2, 1-196.
   Google Scholar
• Olson M, O’Connor M, Schwartz ML. Surgical wound infections: a 5-year prospective study of 20,193 wounds at the Minneapolis VA Medical Center. Ann Surg 1984; 199: 253-9.
   Google Scholar
• American Medical Association. Drug Evaluations Annual 1994. Antimicrobial chemoprophylaxis for surgical patients. 1994; 32: 1317-21.
   Google Scholar
• American Society of Hospital Pharmacists Commission on Therapeutics. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Clin Pharm 1992; 11: 483-513.
   Google Scholar
• Anonymous.. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 1995; 37: 79-82.
   Google Scholar
• Dickinson GM, Bisno AL. Antimicrobial prophylaxis of infection. Infect Dis Clin North Am 1995; 9: 783-804.
   Google Scholar
• Gorbach SL, Condon RE, Conte JE Jr, Kaiser AB, Ledger WJ, Nichols RL. Evaluation of new anti-infective drugs for surgical prophylaxis. Clin Infect Dis 1992; 15, Suppl. 1: 313-38.
   Google Scholar
• Haas DW, Kaiser AB. Antimicrobial prophylaxis of infections associated with foreign bodies. In: Bisno AL, Waldvogel FA, eds, Infections associated with indwelling medical devices, Washington D.C.: American Society for Microbiology Press, 1994: 375.
   Google Scholar
• Hopkins CC. Antibiotic prophylaxis in clean surgery: peripheral vascular surgery, noncardiovascular thoracic surgery, herniorrhaphy, and mastectomy. Rev Infect Dis 1991; 13: Suppl. 10, 869-73.
   Google Scholar
• Kernodle DS, Kaiser AB. Postoperative infections and antimicrobial prophylaxis. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, 4th edn. New York Churchill Livingstone, 1995: 2742-56.
   Google Scholar
• Martin C. The French Study Group on Antimicrobial Prophylaxis in Surgery & the French Society of Anesthesia and Intensive Care. Antimicrobial prophylaxis in surgery: general concepts and clinical guidelines. Infect Cont Hosp Epidemiol 1994; 15: 463-71.
   Google Scholar
• Nichols RC. Antibiotic prophylaxis in surgery. Curr Opin Infect Dis 1994; 7: 647-52.
   Google Scholar
• Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds. Guidelines for clinical care. Arch Surg 1993; 128: 79-88.
   Google Scholar
• Slama TG. Current thoughts and controversies of antibiotic prophylaxis. Curr Opin Infect Dis 1992; 5: 787-93.
   Google Scholar
• Strachan CJL. Antibiotic prophylaxis in peripheral vascular and orthopaedic prosthetic surgery. J Antimicrob Chemother 1993; 31: Suppl. B 65-78.
   Google Scholar
• Cruse PJE, Ford R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin N Am 1980; 60: 27-40.
   Google Scholar
• Leaper DJ. Use of antibiotic prophylaxis in clean non-implant wounds. J Antimicrob Chemother 1998; 41: 501-4.
   Google Scholar
• Brown EM. Antimicrobial prophylaxis in neurosurgery. J Antimicrob Chemother 1993; 31, Suppl. B: 49-63.
   Google Scholar
• Gillespie WJ. Prevention and management of infection after total Joint replacement. Clin Infect Dis 1997; 25: 13107.
   Google Scholar
• Haines SJ, Walters BC. Antibiotic prophylaxis for cerebrospinal fluid shunts: a meta-analysis. Neurosurgery 1994; 34: 87-92.
   Google Scholar
• Infection in Neurosurgery Working Party of the British Society for Antimicrobial Chemotherapy. Antimicrobial prophylaxis in neurosurgery and after head injury. Lancet 1994; 344: 1547-51.
   Google Scholar
• Kreter B, Woods M. Antibiotic prophylaxis for cardio-thoracic operations. Meta-analysis of thirty years of clinical trials. J Thor Card Surg 1992; 104: 590-9.
   Google Scholar
• Langley JM, LeBlanc JC, Drake J, Milner R. Efficacy of antimicrobial prophylaxis in placement of cerebrospinal fluid shunts: meta-analysis. Clin Infect Dis 1993; 17: 98-103.
   Google Scholar
• Mini E, Nobili S, Periti P. Methicillin-resistant staphylococci in clean surgery. Drugs 1997; 54: Suppl. 6, 39-52.
   Google Scholar
• Periti P, Mini E, Mosconi G. Antimicrobial prophylaxis in orthopaedic surgery: the role of teicoplanin. J Antimicrob Chemother 1998; 41: 329-40.
   Google Scholar
• Shapiro M. Prophylaxis in otolaryngologic surgery and neurosurgery: a critical review. Rev Infect Dis 1991; 13, Suppl. 10: 858-68.
   Google Scholar
• Platt R, Zaleznik DF, Hopkins CC, et al. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med.1990; 322: 153-60.
   Google Scholar
• Ranaboldo CJ, Karran SE, Bailey IS, Karran SJ. Antimicrobial prophylaxis in “clean” surgery: hernia repair. J Antimicrob Chemother 1993; 31, Suppl. B: 35-41.
   Google Scholar
• Taylor EW, Byrne DJ, Leaper DJ, Karran SJ, Browne MK, Mitchell KJ. Antibiotic prophylaxis and open groin hernia repair. World J Surg 1997; 21: 811-4.
   Google Scholar
• Burnakis TG. Surgical antimicrobial prophylaxis: principles and guidelines. Pharmacotherapy 1984; 4: 248-71.
   Google Scholar
• Voss A, Milatovic D, Wallrauch-Schwarz C, Rosdahl VT, Braveny I. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13: 50-5.
   Google Scholar
• Maniatis AN, Trougakos IP, Katsanis G, Palermos J, Maniatis NA, Legakis NJ. Changing patterns of bacterial nosocomial infections: a nine-year study in a general hospital. Chemotherapy 1997; 46: 624-6.
   Google Scholar
• Struelens MJ, Ronveaux O, Jans B, Mertens R. Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Groupement pour le Depistage, L’Etude et la Prevention des Infections Hospitalieres. Infect Cont Hosp Epidemiol 1996; 17: 503-8.
   Google Scholar
• Panlilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Contr Hosp Epidemiol 1992; 13: 582-6.
   Google Scholar
• Nichols LR. Postoperative infections in the age of drug-resistant Gram-positive bacteria. Am J Med 1998; 104: 11S-6S.
   Google Scholar
• Hashimoto H, Inoue M, Hayashi I. A survey of Staphylococcus aureus for typing and drug-resistance in various areas of Japan during 1992 and 1993. Jpn J Antibiot 1994; 47: 618-26.
   Google Scholar
• Kimura A, Igarashi H, Ushioda H, Okuzumi K, Kobayashi H, Otsuka T. Epidemiological study of Staphylococcus aureus isolated from Japanese national university and medical college hospitals. Kansenshogaku Zasshi 1992; 66: 1543-9.
   Google Scholar
• Archer GL, Climo MW. Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother 1994; 38: 2231-7.
   Google Scholar
• Lyytikäinen O, Vaara M, Järviluoma E, Rosenqvist K, Tiittanen L, Valtonen V. Increased resistance among Staphylococcus epidermidis isolates in a large teaching hospital over a 12-year period. Eur J Clin Microbiol Infect Dis 1996; 15: 133-8.
   Google Scholar
• Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91, Suppl. 3B: 72-5.
   Google Scholar
• Tripodi MF, Attanasio V, Adinolfi LE, et al. Prevalence of antibiotic resistance among clinical isolates of methicillin-resistant staphylococci. Eur J Clin Microbiol Infect Dis 1994; 13: 148-52.
   Google Scholar
• Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg. 1997; 132: 1320-5.
   Google Scholar
• Weiss CA, Statz CL, Dahms RA, Remucal MJ, Dunn DL, Beilman GJ. Six years of surgical wound infection surveillance at a tertiary care center. Arch Surg 1999; 134: 1041-8.
   Google Scholar
• Gol MK, Karahan M, Ulus AT, et al. Bloodstream, respiratory, and deep surgical wound infections after open heart surgery. J Card Surg 1998; 13: 252-9.
   Google Scholar
• Sanderson PJ. Prophylaxis in orthopaedic implant surgery – should we use a glycopeptide? J Antimicrob Chemother 1998; 41: 322-5.
   Google Scholar
• Hope PG, Kristinsson KG, Norman P, Elson RA. Deep infection of cemented total hip arthroplasties caused by coagu-lase-negative staphylococci. J Bone Joint Surg 1984; 71: 851-5.
   Google Scholar
• James PJ, Butcher IA, Gardner ER, Hamblen DL. Methicillin-resistant Staphylococcus epidermidis in infection of hip arthroplasties. J Bone Joint Surg 1994; 76: 725-7.
   Google Scholar
• Tsukayama DT, Estrada R, Gustilo RB. Infection after total hip arthroplasty. A study of the treatment of one hundred and six infections. J Bone Joint Surg 1996; 78: 512-23.
   Google Scholar
• Went P, Krismer M, Frischhut B. Recurrence of infection after revision of infected hip arthroplasties. J Bone Joint Surg 1995; 77: 307-9.
   Google Scholar
• Periti P, Mini E. Preliminary results of a survey of the use of antimicrobial agents as prophylaxis in orthopaedic surgery. 3rd European Congress of Chemotherapy, Madrid, May 7-10, 2000. Span J Chemother 2000; 13, Suppl. 2: 89.
   Google Scholar
• Bergamini TM, Polk HC Jr. The importance of tissue antibiotic activity in the prevention of operative wound infection. J Antimicrob Chemother 1989; 23: 301-13.
   Google Scholar
• Reeves DS, Lewis DA. Pharmacokinetic aspects of antibacterial prophylaxis. J Antimicrob Chemother. 1993; 31, Suppl. B: 11-21.
   Google Scholar
• Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50: 161-8.
   Google Scholar
• Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326: 281-6.
   Google Scholar
• Sanderson PJ. Antimicrobial prophylaxis in surgery: microbiological factors. J Antimicrob Chemother 1993; 31, Suppl. B: 1-9.
   Google Scholar
• Gorbach SL. The role of cephalosporins in surgical prophylaxis. J Antimicrob Chemother 1989; 23, Suppl. D: 61-70.
   Google Scholar
• Sabath LD. Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins. Antimicrob Agents Chemother 1989; 33: 407-11.
   Google Scholar
• Spencer RC. The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. J Antimicrob Chemother 1998; 41, Suppl. C: 21-7.
   Google Scholar
• Arsura EL, Fazio RA, Wickremesinghe PC. Pseudomembranous colitis following prophylactic antibiotic use in primary cesarian section. Am J Obstet Gynecol 1985; 151: 87-9.
   Google Scholar
• Block BS, Mercer LJ, Ismail MA, Moawad AH. Clostridium difficile associated diarrhea follows peri-operative prophylaxis with cefoxitin. Am J Obstet Gynecol 1985; 153: 835-8.
   Google Scholar
• Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg 1995; 169: 480-3.
   Google Scholar
• Kreisel D, Savel TC, Silver AL, Cunningham JD. Surgical antibiotic prophylaxis and Clostridium difficile toxin positivity. Arch Surg 1995; 130: 989-93.
   Google Scholar
• Privitera G, Scarpellini P, Ortisi G, Nicastro G, Nicolin R, de Lalla F. Prospective study of Clostridium difficile intestinal colonization and disease following single dose antibiotic prophylaxis in surgery. Antimicrob Agents Chemother 1991; 35: 208-10.
   Google Scholar
• Roberts AP, Hughes AW. Complications with antibiotics used prophylactically in joint replacement surgery: a case report of cephradine-induced pseudomembranous colitis. Int Orthopaed 1985; 8: 299-302.
   Google Scholar
• Tan J, Bayne LH, McLeod PJ. Pseudomembranous colitis. A fatal case following prophylactic cephaloridine therapy. JAMA 1979; 242: 749-50.
   Google Scholar
• Yee J, Dixon CM, McLean AP, Meakins JL. Clostridium difficile disease in a department of surgery. The significance of prophylactic antibiotics. Arch Surg 1991; 126: 241-6.
   Google Scholar
• Della Monica P, Bernard E. Fluoroquinolones and surgical prophylaxis. Drugs 1993; 45, Suppl. 2: 102-13.
   Google Scholar
• Mandel LA. Role of quinolones in surgical prophylaxis. Eur J Clin Microbiol Infect Dis 1991; 10: 368-77.
   Google Scholar
• Davey PG, Williams AH. A review of the safety profile of teicoplanin. J Antimicrob Chemother 1991; 27, Suppl. B: 69-73.
   Google Scholar
• Wilson AP. Comparative safety of teicoplanin and van-comycin. Int J Antimicrob Agents 1998; 10: 143-52.
   Google Scholar
• Wood MJ. The comparative efficacy and safety of teicoplanin and vancomycin. J Antimicrob Chemother 1996; 37: 209-22.
   Google Scholar
• Romanelli VA, Howie MB, Myerowitz PD, et al. Intraoperative and postoperative effects of vancomycin administration in cardiac surgery patients: a prospective, double-blind, randomised trial. Crit Care Med 1993; 21: 1124-31.
   Google Scholar
• Southorn PA, Plevak DJ, Wright AJ, Wilson WR. Adverse effects of vancomycin administered in the perioperative period. Mayo Clin Proc 1986; 61: 721-4.
   Google Scholar
• Valero R, Gomar C, Fita G, et al. Adverse reactions to vancomycin prophylaxis in cardiac surgery. J Cardiothor Vasc Anesthesiol 1991; 5: 574-6.
   Google Scholar
• Brogden RN, Peters DH. Teicoplanin. A reappraisal of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy. Drugs 1994; 47: 823-54.
   Google Scholar
• Sahai J, Healy DP, Sheldon MJ, Miller JS, Ruberg SJ, Polk R. Comparison of vancomycin- and teicoplanin-induced histamine release and “red man syndrome”. Antimicrob Agents Chemother 1990; 34: 765-9.
   Google Scholar
• Odio C, Mohs E, Sklar FH, Nelson JD, McCraken GH Jr. Adverse reactions to vancomycin used as prophylaxis for CSF shunt procedures. Am J Dis Child 1984; 138: 17-9.
   Google Scholar
• Benet LZ, Øie S, Schwartz JB. Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbird LE, eds in chief, Molinoff PB, Ruddon RW eds, Goodman Gilman A, consulting ed, Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 9th Edition, New York: McGraw-Hill, 1996: 1707-92.
   Google Scholar
• Mader JT, Cierny G III. The principles of the use of preventive antibiotics. Clin Orthopaed 1984; 190: 75-82.
   Google Scholar
• Neu HC. Cephalosporin antibiotics as applied in surgery of bones and joints. Clin Orthopaed 1984; 190: 50-64.
   Google Scholar
• Bressolle F, Gonçalves F, Gouby A, Galtier M. Pefloxacin clinical pharmacokinetics. Clin Pharmacokinet 1994; 27: 418-46.
   Google Scholar
• Campoli-Richards DM, Brodgen RN, Faulds D. Teicoplanin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential. Drugs 1990; 40: 449-86.
   Google Scholar
• Matzke GR, Zhanel GG, Guay DRP. Clinical pharmaco-kinetics of vancomycin. Clin Pharmacokinet 1986; 11: 257-82.
   Google Scholar
• Rowland, M. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet 1990; 17: 184-209.
   Google Scholar
• Graziani AL, Lawson LA, Gibson GA, Steinberg MA, MacGregor RR. Vancomycin concentrations in infected and noninfected human bone. Antimicrob Agents Chemother 1988; 32: 1320-2.
   Google Scholar
• Massias L, Dubois C, de Lentdecker P, Brodaty O, Fischler M, Farinotti R. Penetration of vancomycin in uninfected sternal bone. Antimicrob Agents Chemother 1992; 36: 2539-41.
   Google Scholar
• Rosina R, Avai A, Suter F, et al. Pharmacokinetics of teicoplanin (T) in human bone. In Program and Abstracts of the 16th International Congress of Chemotherapy, 1989, Jerusalem. Abstract 249.
   Google Scholar
• Wilson APR, Taylor B, Treasure T, et al. Antibiotic prophylaxis in cardiac surgery: serum and tissue levels of teicoplanin, flucloxacillin and tobramycin. J Antimicrob Chemother 1988; 21: 201-12.
   Google Scholar
• Nehrer S, Thalhammer F, Schwameis S, Breyer S, Krotz R. Teicoplanin in the prevention of infection in total hip replacement. Arch Orthopaed Trauma Surg 1998; 118: 32-6.
   Google Scholar
• Daschner FD, Frank U, Kümmel A, et al. Pharmacokinetics of vancomycin in serum and tissue of patients undergoing open-heart surgery. J Antimicrob Chemother 1987; 19: 359-62.
   Google Scholar
• Farber BF, Karchmer AW, Buckley MJ, Moellering RC Jr. Vancomycin prophylaxis in cardiac operations: determination of an optimal dosing regimen. J Thor Cardiovasc Surg 1983; 85: 933-5.
   Google Scholar
• Bergeron MG, Saginur R, Desaulniers D, et al. Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery. Antimicrob Agents Chemother 1990; 34: 1699-702.
   Google Scholar
• Frank UK, Schmidt-Eisenlohr E, Mlangeni D, et al. Penetration of teicoplanin into heart valves and subcutaneous and muscle tissues of patients undergoing open-heart surgery. Antimicrob Agents Chemother 1997; 41: 2559-61.
   Google Scholar
• Martin C, Bourget P, Alaya M, et al. Teicoplanin in cardiac surgery: intraoperative pharmacokinetics and concentrations in cardiac and mediastinal tissues. Antimicrob Agents Chemother 1997; 41: 1150-5.
   Google Scholar
• Miglioli PA, Merlo F, Fabbri A, Padrini R. Teicoplanin concentrations in serum, pericardium, pericardial fluid and thoracic wall fat in patients undergoing cardio-pulmonary bypass surgery. J Antimicrob Chemother 1997; 39: 229-33.
   Google Scholar
• Mini E, Mazzei T, Reali EF, Novelli A, Periti P. Pharmacokinetics of teicoplanin during cardiopulmonary bypass surgery. Int J Clin Pharmacol Res 1989; X: 287-92.
   Google Scholar
• Bunt TJ. Vascular graft infections: a personal experience. Cardiovasc Surg 1993; 1: 489-93.
   Google Scholar
• Maki DG, Bohn MJ, Stolz SM, Kronche GM, Archer CW, Myerowitz PD. Comparative study of cefazolin, cefamandole, and vancomycin for surgical prophylaxis in cardiac and vascular operations. A double-blind randomised trial. J Thor Cardiovasc Surg 1992; 104: 1423-34.
   Google Scholar
• Slaughter MS, Olson MM, Lee JT, Ward HB. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thor Surg 1993; 56: 1063-8.
   Google Scholar
• Periti P, Mini E. The rationale for antimicrobial prophylaxis in prosthetic knee implant surgery. In: Monteleone V, Magri R, Gison L, et al., eds. International Meeting Knee Prostheses, Portici (NA), Italy: Microprint, S.B.R. 1994: 165-177.
   Google Scholar
• Ritter MA, Barzilauskas CD, Faris PM, Keating EM. Vancomycin prophylaxis and elective total Joint arthroplasty. Orthopaedics 1989; 12: 1333-6.
   Google Scholar
• Blomstedt GC, Kytta J. Results of a randomized trial of vancomycin prophylaxis in craniotomy. J Neurosurg 1988; 69: 216-20.
   Google Scholar
• Geraghty J, Feely M. Antibiotic prophylaxis in neuro-surgery. A randomized controlled trial. J Neurosurg 1984; 60: 724-6.
   Google Scholar
• Mollan RAB, Webb CH, Haddock M. A comparison of teicoplanin vs cefamandole in orthopaedic surgical prophylaxis. In Program and Abstracts of the 7th European Congress of Clinical Microbiology and Infectious Diseases, 1995, Vienna 1995, Excerpta Medica, Abstract 758 p. 147.
   Google Scholar
• Periti P, Stringa G, Mini E, and the Italian Study Group for Antimicrobial Prophylaxis in Orthopedic Surgery: Comparative multicenter trial of teicoplanin versus cefazolin for antimicrobial prophylaxis in prosthetic Joint implant surgery. Eur J Clin Microbiol Infect Dis 1999; 18: 113-9.
   Google Scholar
• Suter F, Aval A, Fusco U, Gerundini M, Caprioli S, Maggiolo F. Teicoplanin versus cefamandole in the prevention of infection in total hip replacement. Eur J Clin Microbiol Infect Dis 1994; 13: 793-6.
   Google Scholar
• Wall R, Klenerman L, McCullough C, Fyfe I. A comparison of teicoplanin and cefuroxime as prophylaxis for orthopedic implant surgery: a preliminary report. J Antimicrob Chemother 1988; 21, Suppl. A: 141-6.
   Google Scholar
• Miro JM, Pomar JL, Claramonte X, et al. Vancomycin (Van) versus teicoplanin (Tei) for antibiotic prophylaxis in cardiac surgery. In Program and Abstracts of the 36th ICAAC, New Orleans, Louisiana, 1996. Washington DC: American Society for Microbiology, Abstract J161.
   Google Scholar
• Wilson APR, Treasure T, Grüneberg RN, Sturridge MF, Ross DN. Antibiotic prophylaxis in cardiac surgery: a prospective comparison of two dosage regimens of teicoplanin with a combination of flucloxacillin and tobramycin. J Antimicrob Chemother 1988; 21: 213-23.
   Google Scholar
• Kester RC, Antrum R, Thornton CA, Ramsden CH, Harding I. A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. J Hosp Infect 1999; 41: 233-43.
   Google Scholar
• Maskell JP, Carter JLB, Boyd RB, Williams RJ. Teicoplanin as a prophylactic antibiotic for dental bacteraemia. J Antimicrob Chemother 1986; 17: 651-9.
   Google Scholar
• Shanson DC, Shehata A, Tadayon M, Harris M. Comparison of intravenous teicoplanin with intramuscular amoxycillin for the prophylaxis of streptococcal bacteraemia in dental patients. J Antimicrob Chemother 1987; 20: 85-93.
   Google Scholar
• Speller DCE. Teicoplanin for the prevention of endocarditis after dental procedures in susceptible patients. Int J Antimicrob Agents 1992; 1: S37-S43.
   Google Scholar
• de Lalla F, Pellizzer G, Nicolin R, et al. Teicoplanin (T) prophylaxis for tunneled central venous catheters (TCVC) insertion in patients with AIDS. Program and Abstracts of the 7th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, 1995, Abstract 762.
   Google Scholar
• Lim SH, Smith MP, Salooja N, Machin SJ, Goldstone AH. A prospective randomized study of prophylactic teicoplanin to prevent early Hickman catheter-related sepsis in patients receiving intensive chemotherapy for haematological malignancies. J Antimicrob Chemother 1991; 28: 109-16.
   Google Scholar
• Steer JA, Papini RPG, Wilson APR, McGrouther DA, Nakhia LS, Parkhouse N. Randomized placebo-controlled trial of teicoplanin in the antibiotic prophylaxis of infection following manipulation of burn wounds. Br J Surg. 1997; 84: 848-53.
   Google Scholar
• Franchelli S, Leone MS, Rainero ML, et al. Antibiotic prophylaxis with teicoplanin in patients undergoing breast reconstruction with the transverse rectus abdominis myocutaneous flap. Eur J Plas Surg 1993; 16: 204-7.
   Google Scholar
• Derex MC. Systemic antimicrobial prophylaxis in children with hydrocephalus undergoing surgery for replacement of permanent cerebrospinal fluid shunts. Proph Paed Neurosurg. 1989; 45-53.
   Google Scholar
• Simmons NA, Ball AP, Cawson RA, et al. Antibiotic prophylaxis and infective endocarditis. Lancet 1992; 339: 1292-3.
   Google Scholar
• Mantel H, Haenszel W. Statistical agents of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22: 719-48.
   Google Scholar
• Hoddinott C, Lovering AM, Fernando HC, Dixon JH. Determination of bone and fat concentrations following systemic cefamandole and regional cefuroxime administration in patients undergoing knee arthroplasty. J Antimicrob Chemother. 1990; 26: 823-9.
   Google Scholar
• de Lalla F, Novelli A, Pellizzer G, et al. Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob Agents Chemother 1993; 37: 2693-8.
   Google Scholar
• de Lalla F, Viola R, Pellizzer G, Lazzaroni L, Tramarin A, Fabris P. Regional prophylaxis with teicoplanin in monolateral or bilateral total knee replacement: an open study. Antimicrob Agents Chemother 2000; 44: 316-9.
   Google Scholar
• Hiramatzu K, Aritaka N, Hanaki H, et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
   Google Scholar
• Centers for Disease Control. Staphylococcus aureus with reduced susceptibility to vancomycin – United States. MMWR 1997; 46: 765-6.
   Google Scholar
• Ploy MC, Grélaud C, Martin C, de Lumley L, Denis F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital. Lancet 1998; 351: 1212.
   Google Scholar
• Smith TL, Pearson ML, Wilcox KR, et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
   Google Scholar
• Goldstein FW, Coutrot A, Sieffer A, Acar JF. Percentages and distributions of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother 1990; 34: 899-900.
   Google Scholar
• Cercenado E, Garcìa-Leoni ME, Dìaz MD, et al. Emergence of teicoplanin-resistant coagulase-negative staphy-lococci. J Clin Microbiol 1996; 34: 1765-8.
   Google Scholar
• Bannerman TL, Wadiak DL, Kloos WE. Susceptibility of Staphylococcus species and subspecies to teicoplanin. Antimicrob Agents Chemother 1991; 35: 1919-22.
   Google Scholar
• Maugein J, Pellegrin JL, Brossard G, Fourche J, Leng B, Reiffers J. In vitro activities of vancomycin and teicoplanin against coagulase-negative staphylococci isolated from neu-tropenic patients. Antimicrob Agents Chemother 1990; 34: 901-3.
   Google Scholar
• Felmingham D, Brown DF, Soussy CJ, & the European Glycopeptide Resistance Survey Study Group. European glycopeptide susceptibility survey of gram-positive bacteria for 1995. Diagn Microbiol Infect Dis 1998; 31: 563-71.
   Google Scholar
• Jones ME, Jones RN, Sader H, Verhoef J, Acar J for the SENTRY Antimicrobial Surveillance Program. Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. J Antimicrob. Chemother 1998; 42: 119-21.
   Google Scholar
• Nourse C, Kaufmann M, Byrne M, et al. Clinical isolates of Staphylococcus epidermidis with reduced susceptibilities to teicoplanin in a paediatric hospital in Ireland. J Antimicrob Chemother 1998; 42: 118-9.
   Google Scholar
• Pagano L, Tacconelli E, Tumbarello M, et al. Teicoplanin-resistant coagulase-negative staphylococcal bacteraemia in patients with haematological malignancies: a problem of increasing importance. J Antimicrob Chemother 1997; 40: 738-40.
   Google Scholar
• Sloos JH, van de Klundert JA, Dijkshoorn L, van Boven CP. Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother 1998; 42: 787-91.
   Google Scholar
• O’Connell B, Browne PV, Cafferkey MT, McCann SR. Coagulase-negative staphylococcal bacteraemia treated with teicoplanin. J Antimicrob Chemother 1993; 31: 438-9.
   Google Scholar
• Centers for Disease Control. Interim guidelines for prevention and control of staphylococcal infection associated with reduced susceptibility to vancomycin. MMWR 1997; 46: 626-30.
   Google Scholar
• Hospital Infection Control Practices Advisory Committee. Recommendations for preventing the spread of vancomycin resistance. MMWR 1995; 44: 1-13.
   Google Scholar
• Moellering RC. The spectre of glycopeptide resistance: current trends and future considerations. Am J Med 1998; 104: 3S-6S.
   Google Scholar
• Perl TM. The threat of vancomycin resistance. Am J Med 1999; 106, 26S-37S.
   Google Scholar